Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 1
65
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Treatment outcomes 12 months after antiretroviral therapy initiation in Oman: a nationwide study from the Middle East

, , , , , , , & show all
Pages 63-70 | Received 23 Jan 2021, Accepted 04 Oct 2021, Published online: 26 Oct 2021

References

  • Boender, T. S., Sigaloff, K. C., McMahon, J. H., Kiertiburanakul, S., Jordan, M. R., Barcarolo, J., Ford, N., Rinke de Wit, T. F., & Bertagnolio, S. (2015). Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and meta-analysis. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 61(9), 1453–1461. https://doi.org/10.1093/cid/civ556
  • Brown, A. E., Kall, M. M., Smith, R. D., Yin, Z., Hunter, A., & Delpech, V. C. (2012). Auditing national HIV guidelines and policies: The United Kingdom CD4 Surveillance scheme. The Open AIDS Journal, 6(1), 149–155. https://doi.org/10.2174/1874613601206010149
  • Bucciardini, R., Fragola, V., Abegaz, T., Lucattini, S., Halifom, A., Tadesse, E., Berhe, M., Pugliese, K., Fucili, L., Gregorio, M. D., Mirra, M., Castro, P., Terlizzi, R., Tatarelli, P., Binelli, A., Zegeye, T., Campagnoli, M., Vella, S., Abraham, L., & Godefay, H. (2017). Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in tigray, Ethiopia. BMJ Global Health, 2(3), e000325. https://doi.org/10.1136/bmjgh-2017-000325
  • Elgalib, A., Shah, S., Al-Habsi, Z., Al-Fouri, M., Al-Sawafi, H., Al-Noumani, J., Al-Baloushi, A., Al-Alawi, S., Al-Badi, S., Mohammed, Z., Al-Ghafri, J., Suleimani, A., Al-Mashani, H., Raju, J., Al-Riyami, S., Al-Shukri, M., Wahab, A., Hussain, B., Al-Naabi, K., … Al-Abri, S. (2018). HIV viral suppression in Oman: Encouraging progress toward achieving the United Nations ‘third 90’. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 71, 94–99. https://doi.org/10.1016/j.ijid.2018.04.795
  • Elgalib, A., Shah, S., Al-Habsi, Z., Al-Fouri, M., Lau, R., Al-Kindi, H., Al-Rawahi, B., & Al-Abri, S. (2020a). The cascade of HIV care in Oman, 2015-2018: A population-based study from the Middle East. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 90, 28–34. https://doi.org/10.1016/j.ijid.2019.09.017
  • Elgalib, A., Shah, S., Al-Wahaibi, A., Al-Habsi, Z., Al-Fouri, M., Lau, R., Al-Kindi, H., Al-Rawahi, B., & Al-Abri, S. (2020b). The epidemiology of HIV in Oman, 1984-2018: A nationwide study from the Middle East. Journal of Epidemiology and Global Health, 10(3), 222–229. https://doi.org/10.2991/jegh.k.191208.001
  • Fox, M. P., & Rosen, S. (2015). Retention of adult patients on antiretroviral therapy in Low- and Middle-Income Countries: Systematic Review and meta-analysis 2008-2013. Journal of Acquired Immune Deficiency Syndromes (1999), 69(1), 98–108. https://doi.org/10.1097/QAI.0000000000000553
  • Giordano, T. P., Gifford, A. L., White, A. C., Jr, Suarez-Almazor, M. E., Rabeneck, L., Hartman, C., Backus, L. I., Mole, L. A., & Morgan, R. O. (2007). Retention in care: A challenge to survival with HIV infection. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 44(11), 1493–1499. https://doi.org/10.1086/516778
  • Hassan, A. S., Mwaringa, S. M., Ndirangu, K. K., Sanders, E. J., de Wit, T. F., & Berkley, J. A. (2015). Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in coastal Kenya: A retrospective cohort study. BMC Public Health, 15(1), 478. https://doi.org/10.1186/s12889-015-1814-2
  • Hatano, H., Hunt, P., Weidler, J., Coakley, E., Hoh, R., Liegler, T., Martin, J. N., & Deeks, S. G. (2006). Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 43(10), 1329–1336. https://doi.org/10.1086/508655
  • HIV management in Oman. A guide for health care workers, 3rd edition. (2015). Available from: www.moh.gov.om/en/web/directorate-general-of-disease-surveillance-control/resources. (Accessed 04 December 2020)
  • Horter, S., Bernays, S., Thabede, Z., Dlamini, V., Kerschberger, B., Pasipamire, M., Rusch, B., & Wringe, A. (2019). I don't want them to know": how stigma creates dilemmas for engagement with treat-all HIV care for people living with HIV in eswatini. African Journal of AIDS Research: AJAR, 18(1), 27–37. https://doi.org/10.2989/16085906.2018.1552163
  • Jensen-Fangel, S., Pedersen, L., Pedersen, C., Larsen, C. S., Tauris, P., Møller, A., Sørensen, H. T., & Obel, N. (2004). Low mortality in HIV-infected patients starting highly active antiretroviral therapy: A comparison with the general population. AIDS (London, England), 18(1), 89–97. https://doi.org/10.1097/00002030-200401020-00011
  • Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008). Early mortality among adults accessing antiretroviral treatment programmes in sub-saharan Africa. AIDS (London, England), 22(15), 1897–1908. https://doi.org/10.1097/QAD.0b013e32830007cd
  • Lucas, S. B., Curtis, H., & Johnson, M. A. (2008). National review of deaths among HIV-infected adults. Clinical Medicine (London, England), 8(3), 250–252. https://doi.org/10.7861/clinmedicine.8-3-250
  • Makurumidze, R., Mutasa-Apollo, T., Decroo, T., Choto, R. C., Takarinda, K. C., Dzangare, J., Lynen, L., Van Damme, W., Hakim, J., Magure, T., Mugurungi, O., & Rusakaniko, S. (2020). Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015. PloS one, 15(1), e0222309. https://doi.org/10.1371/journal.pone.0222309
  • Mugavero, M. J., Lin, H. Y., Willig, J. H., Westfall, A. O., Ulett, K. B., Routman, J. S., Abroms, S., Raper, J. L., Saag, M. S., & Allison, J. J. (2009). Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America, 48(2), 248–256. https://doi.org/10.1086/595705
  • Petersen, M. L., van der Laan, M. J., Napravnik, S., Eron, J. J., Moore, R. D., & Deeks, S. G. (2008). Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. AIDS (London, England), 22(16), 2097–2106. https://doi.org/10.1097/QAD.0b013e32830f97e2
  • Rich, M. L., Miller, A. C., Niyigena, P., Franke, M. F., Niyonzima, J. B., Socci, A., Drobac, P. C., Hakizamungu, M., Mayfield, A., Ruhayisha, R., Epino, H., Stulac, S., Cancedda, C., Karamaga, A., Niyonzima, S., Yarbrough, C., Fleming, J., Amoroso, C., Mukherjee, J., … Binagwaho, A. (2012). Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. Journal of Acquired Immune Deficiency Syndromes (1999), 59(3), e35–e42. https://doi.org/10.1097/QAI.0b013e31824476c4
  • Shrestha, R., Altice, F. L., & Copenhaver, M. M. (2019). HIV-Related Stigma, motivation to adhere to antiretroviral therapy, and medication adherence Among HIV-positive methadone-maintained patients. Journal of Acquired Immune Deficiency Syndromes (1999), 80(2), 166–173. https://doi.org/10.1097/QAI.0000000000001891
  • Telele, N. F., Kalu, A. W., Marrone, G., Gebre-Selassie, S., Fekade, D., Tegbaru, B., & Sönnerborg, A. (2018). Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PloS one, 13(7), e0200505. https://doi.org/10.1371/journal.pone.0200505
  • The Joint United Nations Joint Programme on HIV/AIDS (UNAIDS). AIDSinfo. https://aidsinfo.unaids.org. (Accessed 01 Decemeber 2020)
  • The World Health Organisation. HIV drug resistance report. (2019). https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en/. (Accessed 04 November 2020)
  • Tymejczyk, O., Vo, Q., Kulkarni, S. G., Antelman, G., Boshe, J., Reidy, W., Parcesepe, A., Nash, D., & Elul, B. (2021). Tracing corrected estimates of disengagement from HIV care and mortality among patients enrolling in HIV care without overt immunosuppression in Tanzania. AIDS Care, 33(1), 47–53. https://doi.org/10.1080/09540121.2019.1699642
  • UNAIDS Data. (2019). https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf. (Accessed 16 December 2020)
  • Wilson Dib, R., Dandachi, D., Matar, M., Shayya, A., Davila, J. A., Giordano, T. P., & Mokhbat, J. E. (2020). HIV in Lebanon: Reasons for testing, engagement in care, and outcomes in patients with newly diagnosed HIV infections. AIDS and Behavior, 24(8), 2290–2298. https://doi.org/10.1007/s10461-020-02788-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.